EUVIMEDEUVIMED entdecken
Klinische Studie

Prospective Short‐Term Outcomes of Allograft Adipose Matrix ( AAM ) for Vocal Fold Augmentation

Chloe Santa Maria iD, Elizabeth A Shuman iD, Yael E Bensoussan iD, Neel K Bhatt, Jake Morgan iD, Jack Rodman, Kacie La Forest, Lauren Timmons-Sund iD, Michael M Johns, Karla O'Dell

The Laryngoscope · 2025

DOI: 10.1002/lary.70240 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift The Laryngoscope, 2025. Verfasst von Chloe Santa Maria und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Vocal Cord Paralysis, Laryngoplasty, Adipose Tissue, Vocal Cords. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Injection laryngoplasty is a common procedure to improve glottic closure following unilateral vocal fold paralysis (UVFP) or vocal fold atrophy. Allograft adipose matrix (AAM, Renuva, MTF Biologics) supports neoadipogenesis making it a potentially permanent solution. Given the known favorable properties of vocal fold lipoinjection, we hypothesize AAM to be a useful injection material with possible durable results following injection laryngoplasty. Materials and Methods A prospective clinical trial of patients with UVFP underwent injection augmentation laryngoplasty with AAM. Blinded independent laryngologists and expert listeners used pretreatment and 3‐month postinjection videostroboscopy and CAPE‐V assessments to evaluate glottic closure, pliability and voice quality changes. Patient‐reported outcome measures (PROMs) were evaluated.

Results

A total of 21 patients underwent AAM injection; 16 had a diagnosis of unilateral vocal fold paralysis and were included for analysis. There were no adverse reactions. The raters observed an improvement in post‐treatment voice in 81.3% of cases, and CAPE‐V scores showed an average reduction of 32.3 points ( p < 0.01). There was an average reduction in VHI‐10 scores of 11.3 ( p = 0.02). The raters perceived the post‐AAM treatment videostroboscopy exams to be better in 68.8% of cases. Thirty‐seven percent of incomplete glottic closure was considered complete, and there was no change in pliability at 3 months post‐AAM injection.

Conclusions

This is the first study on AAM as an injection material in the vocal fold for augmentation laryngoplasty in unilateral vocal fold paralysis. It appears to be safe and effective on early follow‐up. Additional studies with longer follow‐up are needed. Level of Evidence 4 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vocal Cord ParalysisLaryngoplastyAdipose TissueVocal CordsHumansFemaleProspective StudiesMaleMiddle AgedTreatment OutcomeAllograftsAdultVoice QualityAgedPatient Reported Outcome Measures

Stichwörter der Autor:innen

allograft adipose matrixglottic insufficiencyinjection laryngoplastyvocal fold augmentation

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • USC Voice Center, Department of Otolaryngology-Head & Neck Surgery, University of Southern California, Los Angeles, California, USA.
  • USF Health Voice Center, Department of Otolaryngology-Head and Neck Surgery, University of Southern Florida, Tampa, Florida, USA.
  • Division of Laryngology, Department of Otolaryngology-Head & Neck Surgery, University of Washington School of Medicine, Seattle, Washington, USA.
  • Southern California Clinical and Translational Science Institute (SC CTSI), University of Southern California, Los Angeles, California, USA.

ORCID-Profile: Chloe Santa Maria, Elizabeth A Shuman, Yael E Bensoussan, Jake Morgan, Lauren Timmons-Sund

Zitieren

APA

Santa Maria, C., Shuman, E. A., Bensoussan, Y. E., Bhatt, N. K., Morgan, J., Rodman, J., La Forest, K., Timmons-Sund, L., Johns, M. M., & O'Dell, K. (2025). Prospective Short‐Term Outcomes of Allograft Adipose Matrix ( AAM ) for Vocal Fold Augmentation. The Laryngoscope. https://doi.org/10.1002/lary.70240

Vancouver

Santa Maria C, Shuman EA, Bensoussan YE, Bhatt NK, Morgan J, Rodman J, et al. Prospective Short‐Term Outcomes of Allograft Adipose Matrix ( AAM ) for Vocal Fold Augmentation. The Laryngoscope. 2025. doi:10.1002/lary.70240

BibTeX
@article{SantaMaria2025,
  author = {Santa Maria, Chloe and Shuman, Elizabeth A and Bensoussan, Yael E and Bhatt, Neel K and Morgan, Jake and Rodman, Jack and La Forest, Kacie and Timmons-Sund, Lauren and Johns, Michael M and O'Dell, Karla},
  title = {Prospective Short‐Term Outcomes of Allograft Adipose Matrix ( AAM ) for Vocal Fold Augmentation},
  journal = {The Laryngoscope},
  year = {2025},
  doi = {10.1002/lary.70240}
}
Kostenlos starten →